Wheeler Bio's Stephen Hamilton, Ph.D., and Mike Brem discuss how the company's unique approach to cell line development that provides open-source manufacturing processes and parallel integration between collaborating service providers can simplify the pathway between drug discovery and scalable clinical biomanufacturing.
.svg)
